Market Overview:

According to IMARC Group's latest research publication, "India Diagnostic Imaging Market Size, Share, Trends and Forecast by Modality, Application, End User and Region, 2025-2033", the India diagnostic imaging market size reached USD 1.2 Billion in 2024. Looking forward, the market is expected to reach USD 2.4 Billion by 2033, exhibiting a growth rate of 7.75% during 2025-2033.

This detailed analysis primarily encompasses industry size, business trends, market share, key growth factors, and regional forecasts. The report offers a comprehensive overview and integrates research findings, market assessments, and data from different sources. It also includes pivotal market dynamics like drivers and challenges, while also highlighting growth opportunities, financial insights, technological improvements, emerging trends, and innovations. Besides this, the report provides regional market evaluation, along with a competitive landscape analysis.

Grab a sample PDF of this report: https://www.imarcgroup.com/india-diagnostic-imaging-market/requestsample

Our report includes:

• Market Dynamics
• Market Trends and Market Outlook
• Competitive Analysis
• Industry Segmentation
• Strategic Recommendations

Growth Factors in the India Diagnostic Imaging Market

• Rising Chronic Disease Burden Creating Sustained Equipment Demand

India's diagnostic imaging market is experiencing robust expansion driven by an alarming rise in chronic diseases that require sophisticated diagnostic capabilities. The numbers tell a compelling story—diabetes now affects 77 million Indians, with projections indicating this figure could reach 134 million by 2045 according to the International Diabetes Federation. Cardiovascular diseases account for 28% of all deaths in the country, creating massive demand for specialized imaging procedures like CT angiography and cardiac MRI. Cancer incidence is forecasted to increase to 549 per 100,000 inhabitants by 2031, necessitating advanced imaging for early detection and treatment monitoring. This epidemiological shift is fundamentally changing how healthcare providers invest in diagnostic infrastructure. Hospitals and diagnostic centers are moving away from single-modality setups toward integrated imaging suites capable of handling complex oncologic and cardiometabolic pathways. The medical community increasingly relies on multiphase MRI, PET-CT scans, and high-slice CT systems to detect early lesions and monitor therapy responses. What makes this growth sustainable is that these aren't one-time purchases—chronic disease management requires regular imaging throughout treatment cycles. A diabetes patient might need ultrasound for vascular assessment, while cancer patients undergo multiple scans during chemotherapy. The aging population amplifies this trend, with India's over-60 population expected to reach 143 million, creating substantial ongoing demand for diagnostic solutions tailored to geriatric care needs.

• Government Healthcare Initiatives Expanding Access and Infrastructure

The Indian government's commitment to healthcare transformation is creating favorable conditions for diagnostic imaging market expansion through substantial policy support and financial allocation. The Union Budget saw healthcare allocation increase from Rs 80,517 crore to Rs 90,658 crore, representing a 12.59% jump that signals serious intent. Ayushman Bharat PM-JAY, the world's largest government-funded health insurance program, received Rs 9,406 crore in the current fiscal year, widening coverage for advanced imaging procedures in secondary and tertiary care facilities across the country. This matters because it converts previously unaffordable diagnostic procedures into accessible healthcare services for over 80 crore beneficiaries. The program now covers CT scans, MRI procedures, and other advanced imaging at empanelled hospitals, driving equipment procurement across both public and private sectors. Beyond funding, the government designated AIIMS Delhi, PGIMER Chandigarh, and AIIMS Rishikesh as 'Centres of Excellence for Artificial Intelligence in Healthcare' to promote AI-enabled diagnostic solutions. The Production Linked Incentive scheme has been a game-changer for domestic manufacturing, funding 19 greenfield plants that now produce MRI scanners, CT systems, and other devices previously imported. The Union Budget 2024 introduced changes in basic customs duty for X-ray tubes and flat panel detectors, specifically aimed at supporting indigenous manufacturing under the Phased Manufacturing Programme. These policy measures are creating an ecosystem where diagnostic imaging equipment becomes both more affordable and more accessible—a dual benefit that accelerates market penetration into tier-2 and tier-3 cities.

• Technological Innovation and AI Integration Revolutionizing Diagnostic Capabilities

The diagnostic imaging landscape in India is witnessing a technological revolution that's fundamentally changing how medical diagnostics are performed and interpreted. Artificial intelligence integration has moved from experimental phase to mainstream adoption, with homegrown companies like Qure.ai, Niramai, and SigTuple developing sophisticated AI systems that enhance diagnostic accuracy while reducing interpretation time. These aren't marginal improvements—AI-powered imaging tools are achieving 99.11% sensitivity for pediatric pneumonia detection compared to 69.8% for conventional chest X-rays, demonstrating clear clinical superiority. Under the Ministry of Health's tuberculosis elimination program 'Cough against TB', AI has helped detect an additional 12-16% of TB cases that might have been missed through conventional screening methods. The technology adoption is accelerating because it solves a critical problem—India's severe shortage of trained radiologists. AI doesn't replace doctors but dramatically amplifies their productivity, allowing a single radiologist to interpret many more scans with greater confidence. Global manufacturers are responding with cutting-edge solutions. GE Healthcare's collaboration with NVIDIA and AWS embeds autonomous acquisition and cloud-based analytics into X-ray, ultrasound, and MRI systems. Siemens Healthineers' MAGNETOM Flow platform reduces helium usage by 90% while integrating deep-learning reconstruction algorithms that lower lifetime operating costs and boost image clarity. In July, Mahajan Imaging and Laboratories in Delhi unveiled India's first AI-enabled 3 Tesla MRI Excel scanner, setting new benchmarks for integrated diagnostics. Perhaps most transformative is the development of portable diagnostic devices—handheld ultrasound systems and mobile DR units with hotspot connectivity that funnel images to cloud PACS for instant interpretation. This technology is making expert-level diagnostics possible in rural clinics, corporate wellness camps, and even disaster zones, dramatically expanding the addressable market.

Key Trends in the India Diagnostic Imaging Market

• MRI Systems Leading Modality Growth with Technology Advancement

The modality segmentation of India's diagnostic imaging market reveals fascinating insights about technology preferences and clinical requirements. MRI systems are experiencing particularly strong traction across multiple categories. High-field MRI systems dominate institutional purchases as hospitals seek superior image resolution for complex neurological and orthopedic cases. The trend toward 3 Tesla systems continues accelerating, with these advanced scanners now appearing not just in metro hospitals but increasingly in tier-2 city diagnostic centers as well. What's interesting is the parallel growth in low and mid-field MRI systems, which serve a different market need—these are more affordable, require less infrastructure support, and work well for routine imaging applications in smaller facilities. Open MRI systems like Fujifilm's APERTO Lucent are gaining traction for claustrophobic patients and pediatric cases, addressing patient comfort concerns that previously limited MRI adoption. The big breakthrough is India's first indigenously developed 1.5 Tesla MRI scanner, installed at AIIMS New Delhi for clinical trials. This development is expected to cut examination costs by 30-50%, potentially transforming MRI accessibility. Computed tomography shows equally dynamic patterns. High-end scanners with 64-slice and higher configurations are standard equipment in major hospitals performing complex cardiovascular and oncology imaging. However, mid-range scanners represent the fastest-growing category as smaller hospitals and diagnostic chains invest in capable equipment without premium pricing. Ultrasound remains ubiquitous due to its versatility, safety, and affordability. The evolution from 2D to 3D ultrasound is reshaping obstetrics and gynecology practices, while handheld ultrasound devices are revolutionizing point-of-care diagnostics in emergency rooms and rural health centers. X-ray systems show clear digital migration, with analog systems rapidly being replaced across the country. Digital X-ray offers immediate image availability, remote interpretation capability, and lower radiation doses—advantages that justify higher initial costs. Nuclear imaging, particularly PET and SPECT systems, serves specialized oncology and cardiology applications in tertiary care centers, representing a smaller but high-value market segment.

• Hospitals Dominating End-User Segment While Diagnostic Centers Show Fastest Growth

The end-user dynamics in diagnostic imaging reveal how healthcare delivery is evolving across India. Hospitals currently hold 65.95% of the market, reflecting their central role in medical diagnostics and treatment. Large multispecialty hospitals maintain comprehensive imaging departments with full modality coverage—MRI, CT, PET-CT, nuclear medicine, ultrasound, and conventional radiology. These institutions prioritize latest-generation equipment because diagnostic accuracy directly impacts treatment outcomes and hospital reputation. What's particularly interesting is how hospitals are restructuring their imaging services. Rather than isolated radiology departments, leading hospitals now create integrated diagnostic suites where different modalities work together in streamlined patient pathways. A cardiac patient might undergo ECG, echocardiography, CT angiography, and stress MRI within the same visit, with results feeding directly into electronic health records for immediate physician review. Government hospitals represent a massive but underserved segment. New AIIMS campuses and upgraded district hospitals funded through central schemes are dramatically expanding public sector imaging capacity. These institutions favor durable, easy-to-maintain equipment from established manufacturers, creating opportunities for companies offering comprehensive after-sale support. However, diagnostic centers are where the real growth story unfolds, projected to expand at 8.07% through 2030. Independent diagnostic chains like Mahajan Imaging, Vijaya Diagnostic Centre, and numerous regional players are aggressively expanding into tier-2 and tier-3 cities. Their business model works because they concentrate exclusively on diagnostics, achieving operational efficiencies impossible in hospital radiology departments. These centers invest in patient experience—comfortable waiting areas, quick report delivery, online booking, and home sample collection. They're also pioneering technology adoption, often installing AI-enabled systems and portable devices ahead of hospitals. The PPP model is gaining momentum, with private diagnostic companies partnering with government facilities to install and operate imaging equipment, combining public access with private efficiency. Corporate health screening programs represent another growing end-user category, with companies purchasing bulk diagnostic packages for employee wellness initiatives, creating consistent demand for imaging services.

• South India Leading Market Share with North India Showing Fastest Regional Growth

Regional patterns in India's diagnostic imaging market reflect varying levels of healthcare infrastructure, economic development, and disease prevalence. South India commanded 29.48% of market share in 2024, maintaining its position as the most developed healthcare region. States like Karnataka and Tamil Nadu benefit from high per-capita healthcare spending, dense networks of medical colleges that create skilled workforce availability, and robust medical tourism ecosystems that demand world-class diagnostic facilities. Bangalore and Hyderabad host numerous medical device manufacturing clusters benefiting from established electronics supply chains, creating local sourcing advantages. Mature regulatory compliance regimes in these states enable quicker equipment installation certification, accelerating market deployment. The region pioneered AI-embedded MRI installations and hybrid operating models that blend in-person consultations with teleradiology workflows, setting technology adoption benchmarks for the rest of the country. However, North India emerges as the breakout growth engine, projected to expand at 9.07% through 2030—the fastest regional growth rate. This acceleration stems from multiple catalysts. New AIIMS campuses in states like Bihar, Punjab, and Rajasthan are creating modern healthcare anchors in previously underserved areas. Central government schemes are funding comprehensive upgrades of district hospitals, many of which are installing their first MRI and CT systems. Delhi-NCR functions as a healthcare hub attracting corporate insurance panels and private equity investments into diagnostic center networks. Uttar Pradesh, with its massive population of over 200 million, offers enormous untapped potential—new cancer institutes and cardiac catheterization labs in cities like Lucknow, Kanpur, and Varanasi are driving substantial equipment procurement. Punjab's prosperous agricultural economy supports private healthcare investment, while Haryana leverages proximity to the capital for PPP imaging suites. West and Central India, anchored by Maharashtra and Gujarat, maintains strong steady growth. Mumbai's position as India's financial capital ensures continuous upgrading of corporate hospitals and diagnostic chains serving high-income segments. Pune, Nagpur, and Ahmedabad have emerged as secondary healthcare hubs with growing imaging infrastructure. East and Northeast India represents the most challenging but potentially rewarding market. Infrastructure deficits and lower healthcare spending currently constrain growth, but government focus on these regions through special healthcare programs is beginning to show results in states like West Bengal and Odisha.

• Indigenous Manufacturing Reducing Import Dependence and Costs

A transformative trend reshaping India's diagnostic imaging landscape is the dramatic shift toward domestic manufacturing, fundamentally altering supply chains and cost structures. Historically, approximately 80% of diagnostic medical imaging equipment sold in India was imported, creating foreign exchange burden, longer delivery timelines, and limited after-sale support. This dynamic is changing rapidly under the Production Linked Incentive scheme, which has committed Rs 6,000 crore to medical devices manufacturing. The scheme has already funded 19 greenfield manufacturing plants producing MRI scanners, CT systems, X-ray equipment, and ultrasound machines. In March 2024, Union Minister Mansukh Mandaviya inaugurated 27 bulk drug park projects and 13 medical device manufacturing plants under PLI, creating plug-and-play infrastructure where companies can establish operations with pre-built utilities and regulatory support. The impact is already visible—AIIMS New Delhi installed the country's first indigenously developed linear accelerator and MRI system for clinical trials in March. This breakthrough is expected to slash scan prices by 30-50% and dramatically reduce import dependence. The Budget 2024 customs duty changes on X-ray tubes and flat panel detectors directly support this indigenous manufacturing push by reducing component costs while protecting finished goods manufacturing. IIT-Madras contributed to innovation by introducing a sports-focused AI-powered portable ultrasound scanner for on-field injury evaluation in September 2024. Kerala-based Agappe unveiled its first indigenously manufactured HX series haematology equipment in December 2023. These developments matter because domestic manufacturing addresses multiple pain points simultaneously. Local production reduces equipment costs, making advanced diagnostics more affordable for tier-2 and tier-3 hospitals. Shorter supply chains mean faster delivery and installation. Local manufacturers provide better after-sale support with readily available spare parts and service technicians. Perhaps most importantly, Indian manufacturers can design equipment specifically for Indian conditions—devices that handle power fluctuations, work in hot and humid climates, and incorporate features relevant to prevalent local diseases.

Our comprehensive India diagnostic imaging market outlook reflects both short-term tactical and long-term strategic planning. This analysis is essential for stakeholders aiming to navigate the complexities of the India diagnostic imaging market and capitalize on emerging opportunities.

Leading Companies Operating in the India Diagnostic Imaging Market:

• Siemens Healthineers AG
• GE HealthCare
• Koninklijke Philips N.V.
• FUJIFILM Holdings Corporation
• Canon Medical Systems Corporation

India Diagnostic Imaging Market Report Segmentation:

Breakup by Modality:

• MRI (Low and Mid Field MRI Systems, High Field MRI Systems, and Very High and Ultra High Field MRI Systems)
• Computed Tomography (Low-End Scanners, Mid-Range Scanners, and High-End Scanners)
• Ultrasound (2D Ultrasound, 3D Ultrasound, and Others)
• X-Ray (Analog Systems and Digital Systems)
• Nuclear Imaging (Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT))
• Others

Breakup by Application:

• Cardiology
• Oncology
• Neurology
• Orthopedics
• Gastroenterology
• Gynecology
• Others

Breakup by End User:

• Hospitals
• Diagnostic Centers
• Others

Regional Insights:

• North India
• West and Central India
• South India
• East and Northeast India

Research Methodology:

The report employs a comprehensive research methodology, combining primary and secondary data sources to validate findings. It includes market assessments, surveys, expert opinions, and data triangulation techniques to ensure accuracy and reliability.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

Get Your Customized Market Report Instantly: https://www.imarcgroup.com/request?type=report&id=21405&flag=E

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group 

134 N 4th St. Brooklyn, NY 11249, USA 

Email: [email protected] 

Tel No: (D) +91-120-433-0800 

United States: +1-201-971-6302